Allarity Therapeutics (ALLR) Long-Term Deferred Tax (2020 - 2023)
Allarity Therapeutics' (ALLR) quarterly Long-Term Deferred Tax came in at $17.0 million in Q4 2023, up 30.59% YoY from $13.0 million in Q4 2022, and up 30.59% on a QoQ basis from $13.0 million in Q4 2022.
Allarity Therapeutics (ALLR) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Allarity Therapeutics (ALLR) has 4 years of Long-Term Deferred Tax data on file, last reported at $17.0 million in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 30.59% year-over-year to $17.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $17.0 million (up 30.59% YoY) and the FY2023 annual result came in at $17.0 million, up 30.59% from the prior year.
- Long-Term Deferred Tax rose to $17.0 million in Q4 2023, from $13.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.0 million in Q4 2023 to a low of $81000.0 in Q3 2021.
- A 4-year average of $7.8 million and a median of $7.6 million in 2020 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax soared 47.69% — and 2023, when it soared 30.59%.
- Tracing ALLR's Long-Term Deferred Tax over 4 years: stood at $6.2 million in 2020, then soared by 47.69% to $9.1 million in 2021, then jumped by 42.73% to $13.0 million in 2022, then surged by 30.59% to $17.0 million in 2023.
- The last three Long-Term Deferred Tax figures came in at $17.0 million (Q4 2023), $13.0 million (Q4 2022), and $1.5 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 12.98 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Dec 31, 2021 | 9.10 Mn |
| Sep 30, 2021 | 81,000.00 |
| Dec 31, 2020 | 6.16 Mn |